
Oramed Granted NASH Patent in Europe
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office

Synthetic Biology Startup Seevix Material Sciences Starts Global Marketing Campaign for its Tissue Engineering Scaffold
HUMAN TISSUE REGENERATION IS SEEVIX’S ULTIMATE GOAL Seevix Material Sciences Ltd. is a privately-held biotech company producing high-strength SVX™, a state-of-the-art biopolymer material, inspired by

BiondVax Signs Expanded Agreement with Max Planck Society to Develop Nanosized Antibody Therapies
BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV), a Jerusalem based biopharmaceutical company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases

BactoByte Develops Life-Saving Blood Diagnostic with Quick-1- Hour Turnaround
BactoByte is developing a conceptually new laboratory system that will process a line of assays, delivering clinical-grade results in medical (blood, urine, swabs, spinal fluid),

Terrapeutics Signs Agreement with HIPS to Co-Develop Novel Antibiotics to Treat Incurable Cancers
Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have reached a cooperation agreement to co-develop novel

Neurogenesis & Hadassah Announce Exciting Results from their Multiple Sclerosis Phase 2 Study
Eight of 15 MLS patients who receive NG-01 therapy as spinal injection see better disability scores; inventors say therapy may ‘dramatically improve’ patients’ lives. See

Gyntools Begins Pilot Program for Vaginitis Screening for Women of IDF
Gyntools is about to undertake a pilot study with the Israel Defense Force (IDF) in order to screen for Vaginitis in women who are serving

Ascento Medical & Hadassah Medical Join Forces to establish Innovative Alzheimers/Dementia Clinic
Ascento Medical Ltd has just announced on January 23, 2002, their partnership with Hadassah Medical in order to develop clinics to diagnose, treat, and prevent

EU Tech Fund Invests in Betalin Therapeutics developing Novel Therapies for Diabetes
The European Innovation Council (EIC) Fund has decided to make a direct equity investment in Jerusalem-based Betalin Therapeutics in the amount of 500,000 Euros. The